glp-1 weight loss type 1 diabetes Medications – Community Education Press Note Details: Press Information

Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone

What should people with diabetes expect when they use marijuana

This form repeatedly requires supporting documents in specific scenarios (e.g., proof of payment/Explanation of Benefits from prior insurer, other plan decline notice, Ontario EAP approval/denial)

As GLP-1 use increases, there are likely to be real impacts on food producers, manufacturers and retailers

Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure

This blog walks through key elements that providers may consider including in informed consent documentation for GLP-1 therapies